Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2012

Dec 26, 2012

30643_dirs_2012-12-26_e842416c-9221-4b81-895a-0978db18c22e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2012-12-21

Reporting Person: HILGER JAMES K (Interim CFO, and CAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-21 Common Stock M 1666 $46.26 Acquired 8591 Direct
2012-12-21 Common Stock F 685 $112.64 Disposed 7906 Direct
2012-12-21 Common Stock S 981 $112.20 Disposed 6925 Direct
2012-12-21 Common Stock M 2500 $63.40 Acquired 9425 Direct
2012-12-21 Common Stock F 1408 $112.64 Disposed 8017 Direct
2012-12-21 Common Stock S 1092 $112.20 Disposed 6925 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-21 Stock Appreciation Right $46.26 M 1666 Disposed 2014-03-02 Common Stock (1666) Direct
2012-12-21 Stock Appreciation Right $63.40 M 2500 Disposed 2015-03-31 Common Stock (2500) Direct

Footnotes

F1: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every four months thereafter.

F2: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.